Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1) To identify and review all randomised controlled trials (RCTs) of pharmacotherapy augmentation of treatment‐resistant/refractory anxiety disorders 2) To estimate the efficacy of pharmacotherapy augmentation strategies for each treatment‐resistant/refractory anxiety disorder 3) To identify which factors (clinical, methodological) predict response to pharmacotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242
Quality of Life in Individuals With Anxiety Disorders
Mendlowicz, M. V., & Stein, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.669 · Cited by 955
Hunter, J. E., & Schmidt, F. L. (2000) · International Journal of Selection and Assessment · doi:10.1111/1468-2389.00156 · Cited by 833
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Treatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416
Self-citationDenys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
Hollander, E., Rossi, N. B., Sood, E., & Pallanti, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003730 · Cited by 197
Development of a quality assessment instrument for trials of treatments for depression and neurosis
Moncrieff, J., Churchill, R., Drummond, D. C., & McGuire, H. (2001) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.108 · Cited by 185
Hirschmann, S., Dannon, P. N., Iancu, I., Dolberg, O. T., Zohar, J., & Grunhaus, L. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200010000-00011 · Cited by 89
Research works printed but not linked: 28
- Ackerman, 2002, Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder, Journal of Clinical Psychopharmacology, 22, 309, 10.1097/00004714-200206000-00012 · DOI · Paper page
- Alderson, 2004, Assessment of study quality
- 1994, Diagnostic and statistical manual of mental disorders (DSM-IV)
- Ballenger, 1998, International Consensus group on Depression and Anxiety, Journal of Clinical Psychiatry, 59 Suppl 8, 47
- Bandelow, 2002, World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders, World Journal of Biological Psychiatry, 3, 171, 10.3109/15622970209150621 · DOI · Paper page
- Barlow DH, 2001, Clinical handbook of psychological disorders: A step-by-step treatment manual (3rd Ed.)
- Berlin, 1999, Measuring the quality of trials: The quality of quality scales, JAMA, 282, 1083, 10.1001/jama.282.11.1083 · DOI
- Blake, 1990, A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1, Behavior Therapy, 21, 187
- Blanco, 2003, The evidence-based pharmacological treatment of social anxiety disorder, International Journal of Neuropsychopharmacology, 6, 427, 10.1017/S1461145703003791 · DOI
- Boyer, 1995, Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: A meta-analysis, Psychopharmacology, 10, 45
- Copas, 2001, A sensitivity analysis for publication bias in systematic reviews, Statistical Methods in Medical Research, 10, 251, 10.1177/096228020101000402 · DOI · Paper page
- Davidson, 1998, Treatment of posttraumatic stress disorder with nefazodone, International Clinical Psychopharmacology, 13, 111, 10.1097/00004850-199805000-00003 · DOI
- Deeks, 2003, Cochrane Reviewers’ Handbook 4.2.1 [updated December 2003]
- Goodman, 1989, The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability, Archives of General Psychiatry, 46, 1006, 10.1001/archpsyc.1989.01810110048007 · DOI · Paper page
- Gury, 1999, Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability, Encephale, 25, 470
- Guy, 1976, ECDEU assessment manual for psychopharmacology
- Hamilton, 1959, The assessment of anxiety states by rating, British Journal of Medical Psychology, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
- Hamilton, 1960, A rating scale for depression, Journal of Neurology, Neurosurgery & Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Karno, 1988, The epidemiology of obsessive-compulsive disorder in five US communities, Archives of General Psychiatry, 45, 1094, 10.1001/archpsyc.1988.01800360042006 · DOI · Paper page
- Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey, Archives of General Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- McDougle, 1994, Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics, Archives of General Psychiatry, 51, 302, 10.1001/archpsyc.1994.03950040046006 · DOI · Paper page
- Montgomery, 1999, Obsessive-Compulsive Disorder: A practical guide
- Murray, 1994, The global burden of disease in 1990: summary results, sensitivity analysis and future directions, Bulletine of the World Health Organisation, 72, 495
- Shear, 1992, Panic Disorder Severity Scale (PDSS)
- Spitzer, 1996, Instructional manual for the structured clinical interview for DSM-IV
- Stein, 2000, Pharmacotherapt for posttraumatic stress disorder, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD002795 · DOI
- Stein, 2002, Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study, American Journal of Psychiatry, 159, 1777, 10.1176/appi.ajp.159.10.1777 · DOI · Paper page
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Response rates for CBT for anxiety disorders: need for standardized criteria
Loerinc, A. G., Meuret, A. E., Twohig, M. P., Rosenfield, D., Bluett, E. J., & Craske, M. G. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.08.004 · Cited by 592
Evidence-based clinical guidelines for immigrants and refugees
Pottie, K., Greenaway, C., Feightner, J., Welch, V., Swinkels, H., Rashid, M., Narasiah, L., Kirmayer, L. J., Ueffing, E., MacDonald, N. E., et al. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.090313 · Cited by 526
Pharmacotherapy for post traumatic stress disorder (PTSD)
Stein, D. J., Ipser, J. C., Seedat, S., Sager, C., & Amos, T. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002795.pub2 · Cited by 519
Self-citationLeckman, J. F., Denys, D., Simpson, H. B., Mataix-Cols, D., Hollander, E., Saxena, S., Miguel, E. C., Rauch, S. L., Goodman, W. K., Phillips, K. A., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20669 · Cited by 411
Self-citation
Metadata
- Authors
- Dhansay, Y., Ipser, J., & Stein, D.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2005-07-20
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4256182809
- Cited by
- 48
- References
- 13
- Type
- reference entry
- Language
- en
- Update notices
- new_version (2006-10-18)
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.